Article Details

Ranibizumab (Lucentis) Biosimilars Pipeline Review 2023: Information on Approved Drugs ...

Retrieved on: 2023-12-15 11:15:13

Tags for this article:

Click the tags to see associated articles and topics

Ranibizumab (Lucentis) Biosimilars Pipeline Review 2023: Information on Approved Drugs .... View article details on hiswai:

Excerpt

Lucentis (ranibizumab injection) is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment (Fab) designed for intraocular use.

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up